-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the world of organic chemistry, the synthesis of complex organic molecules is a challenging task that requires a deep understanding of chemical reactivity and synthetic methodologies.
The synthesis of (4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxaMide is a prime example of such a challenge.
This molecule, also known as Cefuroxime, is a semisynthetic antibiotic that belongs to the family of cephalosporins.
The synthesis of this molecule requires a multistep process that involves the synthesis of several key intermediates, which are then assembled through a series of chemical reactions to form the final product.
The synthesis of Cefuroxime can be divided into several synthetic routes, each of which involves the use of different synthetic methodologies and starting materials.
In this article, we will discuss some of the most commonly used synthetic routes for the synthesis of Cefuroxime and highlight some of the key challenges and opportunities associated with each route.
Route 1: The classic synthesis of Cefuroxime involves a twelve-step synthesis that begins with the synthesis of L-alanine and L-cysteine, which are then converted into the key intermediate N-acetyl-L-alanine and N-acetyl-L-cysteine.
These intermediates are then transformed into N-(2,4-dichlorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide and N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, respectively.
These intermediates are then subjected to a series of chemical reactions, including hydrolysis, dehydrogenation, and condensation, which ultimately lead to the formation of the final product, Cefuroxime.
Route 2: Another commonly used synthetic route for the synthesis of Cefuroxime involves the use of a seven-step synthesis that begins with the synthesis of L-alanine and L-cysteine, which are then converted into the key intermediate N-acetyl-L-alanine and N-acetyl-L-cysteine.
These intermediates are then transformed into N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, which is then reduced to form Cefuroxime.
Route 3: A more recent synthetic route for the synthesis of Cefuroxime involves the use of a microwave-assisted synthesis that involves the synthesis of the key intermediate N-(2,4-diflu